Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single Fraction SBRT for Stage I Non-Small Cell Lung Cancer
ConclusionRate of CWT with SF-SBRT is similar to rates published for fractionated SBRT, with most CWT being low grade. Tumor location relative to CW is not a contraindication to SF-SBRT, though rates rise significantly with abutment. Rib D1cc and CW D1cc and D5cc may be used as predictors of CWT.
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Pain | Radiation Therapy | Radiography | Study | Toxicology